Conversion from cyclosporine to rapamycin in renal transplant recipients - Report of an initial experience.

被引:0
|
作者
Dominguez, J [1 ]
Mahalati, K [1 ]
Kiberd, B [1 ]
McAlister, VC [1 ]
MacDonald, AS [1 ]
机构
[1] Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Transplant Program, Halifax, NS B3H 2Y9, Canada
关键词
D O I
10.1097/00007890-199904150-00654
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
629
引用
收藏
页码:S164 / S164
页数:1
相关论文
共 50 条
  • [31] CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE IN HEART-TRANSPLANT RECIPIENTS
    STEVENS, L
    HALBROOK, H
    BERRON, K
    SPEARS, C
    HORMUTH, D
    JOURNAL OF HEART TRANSPLANTATION, 1988, 7 (02): : 119 - 122
  • [32] Hyperhomocysteinemia in renal transplant recipients with cyclosporine
    Kim, SI
    Yoo, TH
    Song, HY
    Hwang, JH
    Lee, HY
    Han, DS
    Moon, JI
    Kim, YS
    Park, KI
    Paeng, KJ
    Choi, KH
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1878 - 1879
  • [33] A pharmacokinetic conversion study of Abbott cyclosporine and Neoral® in stable renal transplant recipients
    Tomlanovich, S
    Pollak, R
    Roza, A
    Merion, R
    Scandling, J
    Greco, R
    Dubé, L
    Awni, W
    Nabulsi, A
    TRANSPLANTATION, 1999, 67 (07) : S163 - S163
  • [34] Cyclosporine pharmacokinetics in stable renal transplant recipients after Neoral conversion.
    Pescovitz, MD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3361 - A3361
  • [35] Delayed Tacrolimus (TAC) to Rapamycin (RAPA) Conversion in Renal Transplant Recipients With DGF/SGF
    Haririan, A.
    Klassen, D.
    Keshtkar, M.
    Drachenberg, C.
    Dowling, T.
    Ramos, E.
    Ugarte, R.
    Cangro, C.
    Weir, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [36] CHANGES IN IMMUNOLOGICAL PARAMETERS AFTER CONVERSION FROM CYCLOSPORINE-A TO AZATHIOPRINE IN RENAL-TRANSPLANT RECIPIENTS
    VERSLUIS, DJ
    BIJMA, AM
    VAESSEN, LMB
    WEIMAR, W
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1989, 11 (02): : 157 - 164
  • [37] GLOMERULAR BARRIER FUNCTION FOLLOWING CONVERSION FROM CYCLOSPORINE-A TO AZATHIOPRINE IN RENAL-TRANSPLANT RECIPIENTS
    ZIETSE, R
    VANLERLANDVANLEEUWEN, ML
    DERKX, FH
    JZERMANS, I
    SCHALEKAMP, MA
    WEIMAR, W
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 1045 - 1045
  • [38] Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
    Handisurya, Ammon
    Kerscher, Corinna
    Tura, Andrea
    Herkner, Harald
    Payer, Berit Anna
    Mandorfer, Mattias
    Werzowa, Johannes
    Winnicki, Wolfgang
    Reiberger, Thomas
    Kautzky-Willer, Alexandra
    Pacini, Giovanni
    Saeemann, Marcus
    Schmidt, Alice
    PLOS ONE, 2016, 11 (01):
  • [39] CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE IN RENAL-ALLOGRAFT RECIPIENTS
    ROCHER, LL
    MILFORD, EL
    KIRKMAN, RL
    CARPENTER, CB
    STROM, TB
    TILNEY, NL
    TRANSPLANTATION, 1984, 38 (06) : 669 - 674
  • [40] Conversion from cyclosporine a to tacrolimus has beneficial effects on blood pressure in longterm renal transplant recipients
    Hillebrand, U
    Gerhardt, U
    Suwelack, B
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 92A - 92A